IRCT20220208053970N1招募中2 期
Comparison of the effectiveness of ACTEMRA (TOCILIZUMAB) and REMICADE (INFLIXIMAB) in patients with Covid19
Shahre-kord University of Medical Sciences0 个研究点目标入组 40 人开始时间: 待定最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 25 years 至 70 years（—）
- 性别
- All
入选标准
- •People with Covid 19 (based on RT-PCR test for SARS-CoV-19 virus or CT scan criteria)
- •People between the ages of 25 and 70
- •Symptoms indicate severe disease (more than 50% of lung involvement in CT or oxygen saturation below 90% or respiratory rate greater than 30 per minute)
- •Elevated CRP, ferritin and other inflammatory markers
排除标准
- •People who test positive for PPD, HCV, HBV and have infections other than Covid 19 infection
- •Pregnancy and pregnancy intention
- •Mild involvement or in the early stages of Covid 19
研究者
相似试验
已完成
不适用
A Non-Interventional Study of RoActemra/Actemra (Tocilizumab) Treatment in Patients With Rheumatoid ArthritisRheumatoid ArthritisNCT01952509Hoffmann-La Roche169
已完成
不适用
A Non-Interventional Study of RoActemra/Actemra (Tocilizumab) in Patients With Moderate to Severe Rheumatoid ArthritisRheumatoid ArthritisNCT01670045Hoffmann-La Roche43
尚未招募
不适用
Evaluation of effectiveness of combined TACE and RFA for medium-sized HCCHCCJPRN-UMIN000003167Kyoto University Graduate School of Medicine100
已完成
不适用
An Observational Study of RoActemra/Actemra (Tocilizumab) in Combination With Methotrexate in Patients With Rheumatoid Arthritis (ACTIVATE)Rheumatoid ArthritisNCT01384461Hoffmann-La Roche251
招募中
不适用
Dental pulp histological respond to MTA, CEM and BIODENTIPulpitis.PulpitisIRCT2017091728804N2Vice Chancellor for research of Kerman University of Medical Sciences40